Quarterly report [Sections 13 or 15(d)]

Net Loss Per Share (Tables)

v3.25.3
Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Anti-dilutive Securities

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because their effect would have been antidilutive:

 

    2025     2024  
   

Nine Months Ended

September 30,

 
    2025     2024  
Stock options     24,012       7,431  
Warrants     677,687       11,628  
Common shares issuable upon conversion of Series H Preferred Stock    

6,265,769

     

 
Total     6,967,468       19,059